H. Ngo

发表

Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia.

Charles P. Lin, Kwok-Kin Wong, A. Roccaro, 2010, Blood.

FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins

J. Griffin, B. Scheijen, H. Ngo, 2004, Oncogene.

B in Waldenstrom macroglobulinemia κ Targeting NF

D. Carrasco, K. Anderson, J. Eeckhoute, 2013 .

Targeting NF-B in Waldenstrom macroglobulinemia

D. Carrasco, K. Anderson, Myles A Brown, 2008 .

Targeting NF-kappaB in Waldenstrom macroglobulinemia.

D. Carrasco, K. Anderson, J. Eeckhoute, 2008, Blood.

macroglobulinemia The Akt pathway regulates survival and homing in Waldenstrom

Charles P. Lin, K. Anderson, S. Treon, 2008 .

1 Targeting NF-κ B in Waldenstrom Macroglobulinemia

D. Carrasco, K. Anderson, J. Eeckhoute, 2008 .

The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia.

Charles P. Lin, K. Anderson, D. McMillin, 2007, Blood.

Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.

Charles P. Lin, Daniel Côté, Charles P Lin, 2007, Blood.

Defining the role of TORC1/2 in multiple myeloma.

Charles P. Lin, C. Rommel, S. Rodig, 2011, Blood.

The bone marrow microenvironment in Waldenstrom macroglobulinemia

A. Roccaro, A. Sacco, A. Azab, 2011, Therapeutic advances in hematology.

Src Tyrosine Kinase Regulates Adhesion and Chemotaxis in Waldenstrom Macroglobulinemia

K. Anderson, A. Roccaro, A. Sacco, 2009, Clinical Cancer Research.

Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features.

Charles P. Lin, A. Kung, A. Roccaro, 2011, Blood.

Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia.

S. Treon, A. Roccaro, A. Sacco, 2006, Blood.

FGFR3 Is Overexpressed Waldenström Macroglobulinemia and Its Inhibition by Dovitinib Induces Apoptosis and Overcomes Stroma-Induced Proliferation

A. Roccaro, A. Sacco, A. Azab, 2011, Clinical Cancer Research.

Cancer Therapy : Preclinical FGFR 3 Is Overexpressed Waldenstr € om Macroglobulinemia and Its Inhibition by Dovitinib Induces Apoptosis and Overcomes Stroma-Induced Proliferation

A. Roccaro, A. Sacco, A. Azab, 2011 .

Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenstrom macroglobulinemia.

K. Anderson, S. Demo, M. Aujay, 2010, Blood.

Carfilzomib-Dependent Selective Inhibition of the Chymotrypsin-like Activity of the Proteasome Leads to Antitumor Activity in Waldenstrom's Macroglobulinemia

M. Aujay, A. Roccaro, A. Sacco, 2011, Clinical Cancer Research.

Targeting the bone marrow in Waldenstrom macroglobulinemia.

A. Roccaro, A. Sacco, A. Azab, 2011, Clinical lymphoma, myeloma & leukemia.

Novel agents in the treatment of Waldenström's macroglobulinemia.

S. Treon, A. Roccaro, A. Sacco, 2007, Clinical lymphoma & myeloma.

SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia.

A. Roccaro, A. Sacco, A. Azab, 2008, Blood.

P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment.

Charles P. Lin, A. Letai, A. Kung, 2012, Blood.

myeloma cells with the bone marrow microenvironment P-selectin glycoprotein ligand regulates the interaction of multiple

Charles P. Lin, A. Letai, A. Kung, 2012 .

Cancer Therapy: Preclinical Carfilzomib-Dependent Selective Inhibition of the Chymotrypsin-like Activity of the Proteasome Leads to Antitumor Activity in Waldenstrom's Macroglobulinemia

M. Aujay, A. Roccaro, A. Sacco, 2011 .

sensitivity to therapy cells with the bone marrow microenvironment and enhances their CXCR 4 inhibitor AMD 3100 disrupts the interaction of multiple myeloma

Charles P. Lin, B. Rollins, N. Munshi, 2009 .

Resveratrol Exerts AntiproliferativeActivity and Induces Apoptosis inWaldenstro« m’s Macroglobulinemia

F. Dammacco, S. Treon, A. Roccaro, 2008 .

The HMG‐CoA inhibitor, simvastatin, triggers in vitro anti‐tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemia

S. Treon, A. Roccaro, A. Sacco, 2008, British journal of haematology.

The bone marrow niche in Waldenström's macroglobulinemia.

A. Roccaro, A. Sacco, A. Azab, 2011, Clinical lymphoma, myeloma & leukemia.

Rho-a and Rac-1 GTPases Play Major and Differential Roles in SDF1α- Induced Cell Adhesion and Chemotaxis in Multiple Myeloma.

Charles P. Lin, A. Roccaro, A. Sacco, 2008 .

LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas.

S. Kauppinen, S. Fernandes, S. Obad, 2012, Blood.

Targeting Akt and Heat Shock Protein 90 Produces Synergistic Multiple Myeloma Cell Cytotoxicity in the Bone Marrow Microenvironment

N. Munshi, P. Richardson, T. Hideshima, 2008, Clinical Cancer Research.

Novel Tumor Suppressor Function of Glucocorticoid-Induced TNF Receptor GITR in Multiple Myeloma

B. Rollins, A. Roccaro, A. Sacco, 2013, PloS one.

microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia.

A. Roccaro, A. Sacco, A. Azab, 2010, Blood.

MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma.

Charles P. Lin, B. Rollins, D. Ribatti, 2009, Blood.

CXCR7 Regulates SDF-1 Induced Adhesion and Homing in Multiple Myeloma.

A. Roccaro, A. Azab, Molly R. Melhem, 2008 .

Dual targeting of the proteasome regulates survival and homing in Waldenstrom macroglobulinemia.

D. Chauhan, S. Treon, T. Hideshima, 2008, Blood.

antitumor activity in Waldenström macroglobulinemia Protein kinase C inhibitor enzastaurin induces in vitro and in vivo

S. Treon, T. Hideshima, A. Leontovich, 2008 .

Protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenstrom macroglobulinemia.

S. Treon, T. Hideshima, A. Leontovich, 2007, Blood.

Signaling between Focal Adhesion Kinase and Trio*

K. Tachibana, H. Ngo, C. Serra-Pages, 2003, The Journal of Biological Chemistry.

RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma.

Charles P. Lin, B. Rollins, A. Roccaro, 2009, Blood.

Key role of microRNAs in Waldenström's macroglobulinemia pathogenesis.

A. Roccaro, A. Sacco, A. Azab, 2011, Clinical lymphoma, myeloma & leukemia.

Combination Mammalian Target of Rapamycin Inhibitor Rapamycin and HSP90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin Has Synergistic Activity in Multiple Myeloma

T. Hideshima, G. Roodman, H. Ngo, 2006, Clinical Cancer Research.

Proteomic analysis of waldenstrom macroglobulinemia.

R. Fonseca, S. Treon, A. Leontovich, 2007, Cancer research.

Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenström's Macroglobulinemia

F. Dammacco, S. Treon, A. Roccaro, 2008, Clinical Cancer Research.

microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia.

B. Rollins, L. Varticovski, A. Roccaro, 2009, Blood.

Role of proteasome inhibition in Waldenström's macroglobulinemia.

A. Roccaro, A. Sacco, A. Azab, 2009, Clinical lymphoma & myeloma.

Novel therapeutic agents in Waldenström's macroglobulinemia.

A. Roccaro, A. Sacco, Emanuel N. Husu, 2009, Clinical lymphoma & myeloma.

The Role of FGFR in the Progression of Waldenstrom's Macroglubulinemia and the Effect of Its Inhibition by TKI-258.

A. Roccaro, A. Sacco, A. Azab, 2009 .

Dual Targeting of -TORC1 and -TORC2 as a New Strategy In the Treatment of Multiple Myeloma

C. Rommel, A. Roccaro, A. Sacco, 2010 .

Perifosine, an Oral Bioactive Novel Akt Inhibitor, Induces In Vitro and In Vivo Antitumor Activity in Waldenstrom Macroglobulinemia.

S. Treon, T. Hideshima, H. Ngo, 2006 .

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

Charles P. Lin, B. Rollins, N. Munshi, 2009, Blood.

In Vivo Mobilization of Multiple Myeloma Cells Out of the Bone Marrow Using the CXCR4 Inhibitor AMD3100 and Bortezomib: Implications for Sensitization of Myeloma Cells to Apoptosis.

Charles P. Lin, A. Kung, C. Pitsillides, 2007 .

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Thanh T. Tran, Dung T. Nguyen, D. Blacker, 2020, The Lancet Neurology.

Eph-B2/Ephrin-B2 Interaction Plays a Major Role in the Adhesion and Proliferation of Waldenstrom's Macroglobulinemia

T. Calimeri, A. Roccaro, A. Sacco, 2011, Clinical Cancer Research.

Stroma-Derived Exosomes Mediate Oncogenesis in Multiple Myeloma

Y. Tai, A. Roccaro, A. Sacco, 2011 .

B622 Rho-A and Rac-1 GTPases in Multiple Myeloma

Charles P. Lin, Melhem, A. Roccaro, 2009 .

microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia.

A. Roccaro, A. Sacco, A. Azab, 2010, Blood.

Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia.

S. Treon, A. Roccaro, A. Sacco, 2006, Blood.

Novel Tumor Suppressor Function of Glucocorticoid-Induced TNF Receptor GITR in Multiple Myeloma

B. Rollins, A. Roccaro, A. Sacco, 2013, PloS one.

Carfilzomib-Dependent Selective Inhibition of the Chymotrypsin-like Activity of the Proteasome Leads to Antitumor Activity in Waldenstrom's Macroglobulinemia

M. Aujay, A. Roccaro, A. Sacco, 2011, Clinical Cancer Research.

Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia.

Charles P. Lin, A. Roccaro, A. Sacco, 2010, Blood.

Carfilzomib Exerts Anti-Neoplastic Activity in Waldenstrom Macroglobulinemia.

S. Demo, M. Aujay, A. Roccaro, 2009 .